2019
DOI: 10.17140/ooj-3-119
|View full text |Cite
|
Sign up to set email alerts
|

Sirtuin Inhibitor as a Novel Cell Cycle Checkpoint and Regulator of the TP53-MDM2 Pathway in Uveal Melanoma

Abstract: Cite this articleGoldsmith ZK, McEwen MW, Kibe MW, et al. Sirtuin inhibitor as a novel cell cycle checkpoint and regulator of the TP53-MDM2 pathway in uveal melanoma. ABSTRACT PurposeThe liver is the most common site of uveal melanoma (UM) metastasis with approximately 50% of UM patients being affected. With no proven therapies that mitigate metastases the mortality rate is 85% within the first year after detection of the liver disease. In this study, we provide a mechanistic understanding of the de-regulation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 26 publications
0
0
0
Order By: Relevance